{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:35:34Z","timestamp":1792787734416,"version":"4.5.0"},"reference-count":99,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Bausch Health Canada Inc","id":[{"id":"https:\/\/ror.org\/05p8nb362","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cutan Med Surg"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>Post-inflammatory hyperpigmentation (PIH) and hypopigmentation are heterogenous conditions that often occur secondary to dermatoses (eg, psoriasis, acne, or atopic dermatitis), cutaneous injury (eg, burns or radiation therapy), infection (viral, bacterial, or fungal), or allergic\/immunologic dysregulation (eg, contact dermatitis or insect bite reactions). The pathophysiology of PIH is complex with multiple pathways implicated in hypermelanosis including ultraviolet radiation exposure, local skin inflammation, and cytokine and growth factor signalling between keratinocytes, melanocytes, and dermal fibroblasts. PIH is a clinical diagnosis based on patient history and clinical examination and may persist for months to years following the resolution of underlying pathophysiological mechanisms, emphasizing the need for prompt diagnosis and management. PIH can be disfiguring and associated with substantial impairments in quality of life and psychosocial well-being. Patients with skin of colour (ie, Fitzpatrick skin types III-VI) have an increased risk of PIH and often present with more pronounced dyspigmentation, highlighting a high unmet need for improved recognition, awareness, and management in this population. Photoprotection is the cornerstone of PIH management given the photosensitive nature of the condition and is recommended in tandem with other treatment options including topical agents (eg, hydroquinone, retinoids, tranexamic acid), light\/laser-based therapies, or chemical peels (glycolic acid and salicylic acid). Despite their use, high-level clinical evidence for these treatment options in PIH remains limited. This review provides an up-to-date overview of PIH pathophysiology, diagnosis and differential diagnosis, and management, and offers expert clinical commentary on practical strategies for identifying, preventing, and managing PIH in routine practice.<\/jats:p>","DOI":"10.1177\/12034754261427395","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:41:32Z","timestamp":1773830492000},"page":"486-497","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["A Review of Post-Inflammatory Pigmentation Changes: Pathophysiology, Diagnosis and Treatment"],"prefix":"10.1177","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9626-6863","authenticated-orcid":false,"given":"Geeta","family":"Yadav","sequence":"first","affiliation":[{"name":"FACET Dermatology, Toronto, ON, Canada"},{"name":"Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada"},{"name":"Division of Dermatology, Women\u2019s College Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5605-3844","authenticated-orcid":false,"given":"Maxwell","family":"Sauder","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada"},{"name":"Division of Dermatology, Department of Medicine, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Siddha","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada"},{"name":"Division of Dermatology, Women\u2019s College Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8527-4163","authenticated-orcid":false,"given":"Rami","family":"Zeinab","sequence":"additional","affiliation":[{"name":"Bausch Health Canada Inc, Laval, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Barakat","sequence":"additional","affiliation":[{"name":"Bausch Health Canada Inc, Laval, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7469-5082","authenticated-orcid":false,"given":"Marissa","family":"Joseph","sequence":"additional","affiliation":[{"name":"FACET Dermatology, Toronto, ON, Canada"},{"name":"Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada"},{"name":"Division of Dermatology, Women\u2019s College Hospital, Toronto, ON, Canada"},{"name":"Department of Pediatrics, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada"},{"name":"Section of Dermatology, Division of Paediatric Medicine, The Hospital for Sick Children, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"e_1_3_3_2_2","volume-title":"Postinflammatory Hyperpigmentation","author":"Lawrence E","year":"2024","unstructured":"Lawrence E, Al Aboud KM. Postinflammatory Hyperpigmentation. StatPearls Publishing LLC; 2024."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20142353"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2009.08077"},{"issue":"5","key":"e_1_3_3_5_2","first-page":"46","article-title":"Willingness-to-pay and time trade-off: the burden of disease in patients with benign hyperpigmentation","volume":"12","author":"Maymone MBC","year":"2019","unstructured":"Maymone MBC, Rajanala S, Widjajahakim R, Secemsky E, Saade D, Vashi NA. Willingness-to-pay and time trade-off: the burden of disease in patients with benign hyperpigmentation. J Clin Aesthet Dermatol. 2019;12(5):46-48.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.2147\/ccid.S158129"},{"issue":"5","key":"e_1_3_3_7_2","first-page":"18","article-title":"Psychosocial impact of postinflammatory hyperpigmentation in patients with acne vulgaris","volume":"10","author":"Darji K","year":"2017","unstructured":"Darji K, Varade R, West D, Armbrecht ES, Guo MA. Psychosocial impact of postinflammatory hyperpigmentation in patients with acne vulgaris. J Clin Aesthet Dermatol. 2017;10(5):18-23.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.24625.1"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-009-8703-8"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2019.07.013"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.2147\/ccid.S245043"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.01.035"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.13038"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.237"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20269"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1089\/ten.TEC.2011.0676"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114182"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.04.118"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.2147\/ccid.S385162"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.02.025"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3385"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.4081\/dr.2021.8223"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.2003.00126.x"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-44766-3_12"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12780"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1009137"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14747"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.01.036"},{"issue":"7","key":"e_1_3_3_29_2","first-page":"20","article-title":"Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color","volume":"3","author":"Davis EC","year":"2010","unstructured":"Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3(7):20-31.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.2165\/11536930-000000000-00000"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00643-2"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.4399"},{"issue":"9","key":"e_1_3_3_33_2","first-page":"1","article-title":"Topical treatments for melasma and postinflammatory hyperpigmentation","volume":"11","author":"Lynde CB","year":"2006","unstructured":"Lynde CB, Kraft JN, Lynde CW. Topical treatments for melasma and postinflammatory hyperpigmentation. Skin Therapy Lett. 2006;11(9):1-6.","journal-title":"Skin Therapy Lett"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2021.1981814"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.12788\/j.sder.2018.027"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19566"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.12.065"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00759-7"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0333-6"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.02.053"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/der2.70016"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.790125"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.5414\/alx02272e"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2025.2465869"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_295_18"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16954"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1177\/12034754241265716"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48840"},{"issue":"4","key":"e_1_3_3_49_2","first-page":"365","article-title":"An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation","volume":"81","author":"Cook-Bolden FE","year":"2008","unstructured":"Cook-Bolden FE, Hamilton SF. An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation. Cutis. 2008;81(4):365-371.","journal-title":"Cutis"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1225"},{"issue":"6","key":"e_1_3_3_51_2","first-page":"362","article-title":"A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation","volume":"74","author":"Grimes PE.","year":"2004","unstructured":"Grimes PE. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation. Cutis. 2004;74(6):362-368.","journal-title":"Cutis"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17189"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0733-8635(05)70150-9"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.140665"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1177\/12034754211035091"},{"issue":"1","key":"e_1_3_3_56_2","first-page":"45","article-title":"Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study","volume":"77","author":"Grimes P","year":"2006","unstructured":"Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Cutis. 2006;77(1):45-50.","journal-title":"Cutis"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199305203282002"},{"issue":"7","key":"e_1_3_3_58_2","first-page":"25","article-title":"Efficacy and safety of clindamycin phosphate 1.2% and tretinoin 0.025% gel for the treatment of acne and acne-induced post-inflammatory hyperpigmentation in patients with skin of color","volume":"5","author":"Callender VD","year":"2012","unstructured":"Callender VD, Young CM, Kindred C, Taylor SC. Efficacy and safety of clindamycin phosphate 1.2% and tretinoin 0.025% gel for the treatment of acne and acne-induced post-inflammatory hyperpigmentation in patients with skin of color. J Clin Aesthet Dermatol. 2012;5(7):25-32.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12301"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1975.01630130042004"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15242"},{"issue":"1","key":"e_1_3_3_62_2","first-page":"67","article-title":"Efficacy and safety of a new triple-combination agent for the treatment of facial melasma","volume":"72","author":"Taylor SC","year":"2003","unstructured":"Taylor SC, Torok H, Jones T, et al. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis. 2003;72(1):67-72.","journal-title":"Cutis"},{"issue":"2","key":"e_1_3_3_63_2","article-title":"Triple combination cream is an effective treatment for post-inflammatory hyperpigmentation","volume":"56","author":"Baumann L","year":"2007","unstructured":"Baumann L, Grimes P, Pandya AG, Rendon M. Triple combination cream is an effective treatment for post-inflammatory hyperpigmentation. J Am Acad Dermatol. 2007;56(2):AB171.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-024-01176-2"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0149-2918(98)80076-3"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12986"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.2147\/ccid.S394889"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.3390\/cosmetics9050108"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15561"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12051"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1111\/ics.12626"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/ics.12694"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16080"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13615"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.36849\/jdd.9093"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.02.013"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17344"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0906-6705.2005.00309.x"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04834.x"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2009.00470.x"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0909-752X.2006.00186.x"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09477.x"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1111\/srt.12107"},{"issue":"2","key":"e_1_3_3_84_2","first-page":"14","article-title":"Methimazole in the treatment of melasma: a clinical and dermascopic study","volume":"14","author":"Farag A","year":"2021","unstructured":"Farag A, Hammam M, Alnaidany N, et al. Methimazole in the treatment of melasma: a clinical and dermascopic study. J Clin Aesthet Dermatol. 2021;14(2):14-20.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1159\/000088509"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.36849\/jdd.6367"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13755"},{"issue":"4","key":"e_1_3_3_88_2","first-page":"37","article-title":"Assessing the effectiveness of stabilized cysteamine 5% cream compared to hydroquinone 4%\/ascorbic acid 3% combination cream in treating acne-induced post-inflammatory hyperpigmentation: a randomized, controlled study","volume":"17","author":"Ahmadi K","year":"2024","unstructured":"Ahmadi K, Miri A, Bizaval Z, et al. Assessing the effectiveness of stabilized cysteamine 5% cream compared to hydroquinone 4%\/ascorbic acid 3% combination cream in treating acne-induced post-inflammatory hyperpigmentation: a randomized, controlled study. J Clin Aesthet Dermatol. 2024;17(4):37-41.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.179088"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17535"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.4103\/pigmentinternational.pigmentinternational_22_19"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1396-0296.2004.04020.x"},{"key":"e_1_3_3_93_2","first-page":"154","volume-title":"Aesthetics and Cosmetic Surgery for Darker Skin Types","author":"Sarkar R","year":"2008","unstructured":"Sarkar R. Medium-depth chemical peels and deep chemical peels. In: Grimes PE, ed. Aesthetics and Cosmetic Surgery for Darker Skin Types. Lippincott Williams & Wilkins; 2008:154-169."},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1097\/dss.0000000000002813"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.1097\/dss.0000000000000642"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2008.34383.x"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.4103\/jcas.Jcas_135_18"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2077.172196"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.36849\/jdd.8268"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.09.017"}],"container-title":["Journal of Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754261427395","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/12034754261427395","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754261427395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:17:02Z","timestamp":1792300622000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/12034754261427395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/12034754261427395"],"URL":"https:\/\/doi.org\/10.1177\/12034754261427395","relation":{},"ISSN":["1203-4754","1615-7109"],"issn-type":[{"value":"1203-4754","type":"print"},{"value":"1615-7109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]}}}